SCHEMBL5354836

SCHEMBL5354836

CCCCC(CC)COC(C)(C)OCC(CC)CCCC

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
ATM Q13315 1/20 0.47
ALDH1A1 P00352 7/20 0.46
RECQL P46063 1/20 0.42
CA2 P00918 4/20 0.41
LMNA P02545 2/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37
MMP14 P50281 1/20 0.37
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2280801 0.87 CYP3A4 (0.52) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL29460338 0.83 CYP3A4 (0.48) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL19822055 0.83 CYP3A4 (0.48) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL17162896 0.82 CYP3A4 (0.49) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL30940561 0.82 CYP3A4 (0.47) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL26964331 0.82 CYP3A4 (0.47) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL17162897 0.82 CYP3A4 (0.47) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL11927544 0.81 CYP3A4 (0.46) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL28715606 0.81 CYP3A4 (0.50) CYP3A4L3MBTL1TSHRTDP1ATM
SCHEMBL29690282 0.80 CYP3A4 (0.46) CYP3A4L3MBTL1TSHRTDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353806-A1 SYNTHESIS OF LEVULINIC ACID BY HYDRATION OF FURFURYL ALCOHOL IN THE PRESENCE OF A HOMOGENEOUS ACID CATALYST AND OF A SOLVENT BASED ON ETHER AND/OR ACETALS IFP Energies Nouvelles (FR) 2025-11-20 US claimed
WO-2023232427-A1 SYNTHESIS OF LEVULINIC ACID BY HYDRATION OF FURFURYL ALCOHOL IN THE PRESENCE OF A HOMOGENEOUS ACID CATALYST AND OF A SOLVENT BASED ON ETHER AND/OR ACETALS IFP Energies Nouvelles (FR) 2023-12-07 WO claimed
EP-0860411-B1 Improved catalytic composition for the conversion of ethylene to alpha olefins INST FRANCAIS DU PETROLE (FR) 2003-10-29 EP claimed
US-6221986-B1 CATALYTIC OLIGOMERIZATION INSTITUT FRANCAIS DU PETROLE (FR) 2001-04-24 US claimed
US-6103654-A Catalytic composition and a process for converting ethylene to light alpha olefins INSTITUT FRANCAIS DU PETROLE (FR) 2000-08-15 US claimed
US-12544733-B2 Gas/liquid oligomerization reactor having successive zones with variable diameters IFP Energies Nouvelles (FR) 2026-02-10 US disclosed
US-12479780-B2 Oligomerisation process comprising a step of recycling a pre-cooled solvent IFP Energies Nouvelles (FR) 2025-11-25 US disclosed
US-20250353806-A1 SYNTHESIS OF LEVULINIC ACID BY HYDRATION OF FURFURYL ALCOHOL IN THE PRESENCE OF A HOMOGENEOUS ACID CATALYST AND OF A SOLVENT BASED ON ETHER AND/OR ACETALS IFP Energies Nouvelles (FR) 2025-11-20 US disclosed
US-20250296908-A1 METHOD FOR SEPARATING LEVULINIC ACID BY THERMAL SEPARATION IN THE PRESENCE OF A FLUX IFP Energies Nouvelles (FR) 2025-09-25 US disclosed
US-12364960-B2 Method for oligomerization in a reactor comprising a gas/liquid double distributor IFP Energies Nouvelles (FR) 2025-07-22 US disclosed
US-12312288-B2 Gas/liquid oligomerization reactor comprising transverse internals IFP Energies Nouvelles (FR) 2025-05-27 US disclosed
US-20250084014-A1 OLIGOMERISATION PROCESS COMPRISING A STEP OF RECYCLING A PRE-COOLED SOLVENT IFP Energies Nouvelles (FR) 2025-03-13 US disclosed
US-7060860-B2 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling INSTITUT FRANCAIS DU PETROLE (FR) 2006-06-13 US disclosed
US-6828269-B2 Chromium compound,aryloxy compound of a magnesium, calcium, strontium and barium; hydrocarbylaluminum and aluminoxane compounds INSTITUT FRANCAIS DU PETROLE (FR) 2004-12-07 US disclosed
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling INSTITUT FRANCAIS DU PETROLE (FR) 2003-12-04 US disclosed
US-20010023281-A1 Catalytic composition and a process for oligomerizing ethylene, in particular to 1-hexene INSTITUT FRANCAIS DU PETROLE (FR) 2001-09-20 US disclosed
US-6235956-B1 ACETALIZATION OF KETONES WITH TETRAHYDROFURAN ALCOHOL INSTITUT FRANCAIS DU PETROLE (FR) 2001-05-22 US disclosed
US-6221986-B1 CATALYTIC OLIGOMERIZATION INSTITUT FRANCAIS DU PETROLE (FR) 2001-04-24 US disclosed
US-6103654-A Catalytic composition and a process for converting ethylene to light alpha olefins INSTITUT FRANCAIS DU PETROLE (FR) 2000-08-15 US disclosed
US-5811619-A Method of production of improved purity light alpha olefines by ogliomerisation of ethylene INSTITUT FRANCAIS DU PETROLE (FR) 1998-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12544733-B2 Gas/liquid oligomerization reactor having successive zones with variable diameters NOD1, VAT1, DECR1 CYP3A4 382/4885L3MBTL1 2645/4885TSHR 3038/4885
US-12479780-B2 Oligomerisation process comprising a step of recycling a pre-cooled solvent COG4, PRPF40A, PRPF6 CYP3A4 239/4885L3MBTL1 4220/4885TSHR 4741/4885
US-12312288-B2 Gas/liquid oligomerization reactor comprising transverse internals DCXR, OTUB1, INF2 CYP3A4 338/4885L3MBTL1 3593/4885TSHR 2383/4885
US-20250084014-A1 OLIGOMERISATION PROCESS COMPRISING A STEP OF RECYCLING A PRE-COOLED SOLVENT COG4, PRPF40A, PRPF6 CYP3A4 239/4885L3MBTL1 4220/4885TSHR 4741/4885
US-12364960-B2 Method for oligomerization in a reactor comprising a gas/liquid double distributor DUOX2, COASY, DUOX1 CYP3A4 453/4885L3MBTL1 4330/4885TSHR 4176/4885
US-20030225303-A1 Hydroformylation process employing a cobalt-based catalyst in a non-aqueous liquid with improved catalyst recycling NUDT1, AP2S1, SRSF1 CYP3A4 3120/4885L3MBTL1 1192/4885TSHR 3055/4885
US-20250296908-A1 METHOD FOR SEPARATING LEVULINIC ACID BY THERMAL SEPARATION IN THE PRESENCE OF A FLUX LDHA, PFN1, CYBA CYP3A4 1010/4885L3MBTL1 4709/4885TSHR 3654/4885
US-20250353806-A1 SYNTHESIS OF LEVULINIC ACID BY HYDRATION OF FURFURYL ALCOHOL IN THE PRESENCE OF A HOMOGENEOUS ACID CATALYST AND OF A SOLVENT BASED ON ETHER AND/OR ACETALS ADH1C, ADH1A, ADH5 CYP3A4 381/4885L3MBTL1 3330/4885TSHR 4455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.